Top

Published in:

Open Access 01-12-2021 | Review

Measuring vitamin C in critically ill patients: clinical importance and practical difficulties—Is it time for a surrogate marker?

Authors: Sander Rozemeijer, Frans A. L. van der Horst, Angélique M. E. de Man

Published in: Critical Care | Issue 1/2021

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2021. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2021. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901.

Fowler AA III, Syed AA, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.CrossRefPubMedPubMedCentral

Zabet M, Mohammadi M, Ramezani M, Khalili H. Effect of high-dose Ascorbic acid on vasopressor′s requirement in septic shock. J Res Pharm Pract. 2016;5:94–100.CrossRefPubMedPubMedCentral

Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017;151:1229–38.CrossRefPubMed

Moskowitz A, Huang DT, Hou PC, et al. Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA. 2020;324:642–50.CrossRefPubMedPubMedCentral

Fowler AA 3rd, Truwit JD, Hite RD, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respi-ratory failure: The CITRIS-ALI randomized clinical trial. JAMA. 2019;322:1261–70.CrossRefPubMedPubMedCentral

Iglesias J, Vassallo AV, Patel VV, Sullivan JB, Cavanaugh J, Elbaga Y. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: the ORANGES trial. Chest. 2020;158:164–73.CrossRefPubMed

Chang P, Liao Y, Guan J, et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock: a randomized controlled trial. Chest. 2020;158:174–82.CrossRefPubMed

Fujii T, Udy AA. Additional trials of vitamin C in septic shock: a bag of mixed fruit. Chest. 2020;158:13–4.CrossRefPubMed

Mohamed ZU, Prasannan P, Moni M, et al. Vitamin C therapy for routine care in septic shock (ViCTOR) trial: effect of intravenous vitamin C, thiamine, and hydrocortisone administration on inpatient mortality among patients with septic shock. Indian J Crit Care Med. 2020;24:653–61.CrossRefPubMedPubMedCentral

10.

Wani SJ, Mufti SA, Jan RA, et al. Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: results from an open label randomised controlled clinical trial and a review of the literature. Infect Dis. 2020;52:271–8.CrossRef

11.

Hwang SY, Ryoo SM, Park JE, et al. Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study. Intensive Care Med. 2020;46:2015–25.CrossRefPubMedPubMedCentral

12.

Fujii T, Luethi N, Young PJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydro-cortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA. 2020;323:423–31.CrossRefPubMedPubMedCentral

13.

Scholz SS, Borgstedt R, Ebeling N, Menzel LC, Jansen G, Rehberg S. Mortality in septic patients treated with vitamin C: a systematic meta-analysis. Crit Care. 2021;25:17.CrossRefPubMedPubMedCentral

14.

Spoelstra-de Man AME, Elbers PWG, Oudemans-Van Straaten HM. Vitamin C: should we supplement? Curr Opin Crit Care. 2018;24:248–55.CrossRefPubMedPubMedCentral

15.

Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. 2017;21:300.CrossRefPubMedPubMedCentral

16.

Gardner R, Liu X, Wang Y, et al. Vitamin C levels amongst initial survivors of out of hospital cardiac arrest. Resuscitation. 2020;156:190–3.CrossRefPubMedPubMedCentral

17.

Rozemeijer S, Spoelstra-de Man AME, Coenen S, et al. Estimating vitamin C status in critically ill patients with a novel point-of-care oxidation-reduction potential measurement. Nutrients. 2019;11:1031.CrossRefPubMedPubMedCentral

18.

Bar-Or D, Bar-Or R, Rael LT, Brody EN. Oxidative stress in severe acute illness. Redox Biol. 2015;4:340–5.CrossRefPubMedPubMedCentral

19.

Anand T, Skinner R. Vitamin C in burns, sepsis, and trauma. J Trauma Acute Care Surg. 2018;85:782–7.CrossRefPubMed

20.

Horton JW. Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology. 2003;189:75–88.CrossRefPubMed

21.

Oudemans-van Straaten HM, Spoelstra-de Man AM, de Waard MC. Vitamin C revisited. Crit Care. 2014;18:460.CrossRefPubMedPubMedCentral

22.

Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis. 2016;22:463–93.CrossRefPubMedPubMedCentral

23.

Jackson TS, Xu A, Vita JA, Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res. 1998;83:916–22.CrossRefPubMed

24.

Karlsen A, Blomhoff R, Gundersen TE. Stability of whole blood and plasma ascorbic acid. Eur J Clin Nutr. 2007;61:1233–6.CrossRefPubMed

25.

Pullar JM, Bayer S, Carr AC. Appropriate handling, processing and analysis of blood samples is essential to avoid oxidation of vitamin C to dehydroascorbic acid. Antioxidants (Basel). 2018;7:29.CrossRefPubMed

26.

Washko PW, Welch RW, Dhariwal KR, Wang Y, Levine M. Ascorbic acid and dehydroascorbic acid analyses in biological samples. Anal Biochem. 1992;204:1–14.CrossRefPubMed

27.

Collie JTB, Greaves RF, Jones OAH, Eastwood G, Bellomo R. Vitamin C measurement in critical illness: challenges, methodologies and quality improvements. Clin Chem Lab Med. 2020;58:460–70.CrossRefPubMed

28.

Lykkesfeldt J. Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: analytical reproducibility and long-term stability of plasma samples subjected to acidic deproteinization. Cancer Epidemiol Biomark Prev. 2007;16:2513–6.CrossRef

29.

Lykkesfeldt J, Tveden-Nyborg P. The pharmacokinetics of vitamin C. Nutrients. 2019;2412:11.

30.

Koshiishi I, Mamura Y, Liu J, Imanari T. Evaluation of an acidic deproteinization for the measurement of ascorbate and dehydroascorbate in plasma samples. Clin Chem. 1998;44:863–8.CrossRefPubMed

31.

Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996;63:760–5.CrossRefPubMed

32.

de Grooth HJ, Manubulu-Choo WP, Zandvliet AS, et al. Vitamin C pharmacokinetics in critically ill patients: a randomized trial of four IV regimens. Chest. 2018;153:1368–77.CrossRefPubMed

33.

Benzie IFF. An automated, specific, spectrophotometric method for measuring ascorbic acid in plasma (EFTSA). Clin Biochem. 1996;29:111–6.CrossRefPubMed

34.

Robitaille L, Hoffer LJ. A simple method for plasma total vitamin C analysis suitable for routine clinical laboratory use. Nutr J. 2016;15:40.CrossRefPubMedPubMedCentral

35.

Bernasconi L, Saxer C, Neyer P, Huber AR, Steuer C. Suitable preanalytical conditions for vitamin C measurement in clinical routine. SDRP J Food Sci Technol. 2018;3:1–8.CrossRef

36.

Rael LT. RedoxSYS^TM ORP scientific data synopsis. Greenwood Village, CO: Luoxis Diagnostics, Inc; 2014.

37.

Rael LT, Bar-Or R, Kelly MT, Carrick MM, Bar-Or D. Assessment of oxidative stress in patients with an isolated traumatic brain injury using disposable electrochemical test strips. Electroanalysis. 2015;27:2567–73.CrossRef

38.

Polson D, Villalba N, Freeman K. Optimization of a diagnostic platform for oxidation-reduction potential (ORP) measurement in human plasma. Redox Rep. 2018;23:125–9.CrossRefPubMedPubMedCentral

39.

Bobe G, Cobb TJ, Leonard SW, et al. Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome. Redox Biol. 2017;12:121–8.CrossRefPubMedPubMedCentral

40.

Buettner GR, Jurkiewicz BA. Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat Res. 1996;145:532–41.CrossRefPubMed

Title: Measuring vitamin C in critically ill patients: clinical importance and practical difficulties—Is it time for a surrogate marker?
Authors: Sander Rozemeijer
Frans A. L. van der Horst
Angélique M. E. de Man
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: Critical Care / Issue 1/2021
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-021-03670-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Measuring vitamin C in critically ill patients: clinical importance and practical difficulties—Is it time for a surrogate marker?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region

Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units

Intensive care doctors and nurses personal preferences for Intensive Care, as compared to the general population: a discrete choice experiment

The knowns and unknowns of perfusion disturbances in COVID-19 pneumonia

Predictive power of extubation failure diagnosed by cough strength: a systematic review and meta-analysis

Seasonal trends of incidence and outcomes of cardiogenic shock : findings from a large, nationwide inpatients sample with 441,696 cases